A credible regulatory system for medical cannabis must be founded on advanced medical knowledge, scientific research and the highest professional standards. Within this context, the strategic partnership between the National Cannabis Control Agency and the University of Medicine, Tirana, establishes a sustainable framework that connects regulatory governance with the country’s leading academic and clinical expertise.  

The Agreement promotes cooperation in scientific research, professional education and capacity building, supporting the development of a regulatory system centred on patient safety, product quality and the protection of public health. Through this partnership, opportunities are created for joint research initiatives, professional training programmes and collaborative projects that foster the continuous advancement of scientific knowledge.

A defining element of the partnership is the integration of clinical expertise into regulatory decision-making. The active involvement of healthcare professionals and academic experts supports the continuous assessment of international scientific developments, contributes to the development of modern regulatory standards and strengthens public policies focused on safety, quality and the responsible medical use of cannabis.

The partnership also encourages a culture of innovation and scientific excellence by creating lasting links between academic research, clinical practice and public administration. This collaborative approach enhances the quality of regulatory decisions while strengthening national institutional capacity to address emerging challenges within a rapidly evolving sector.

Aligned with European Union standards and international best practices, this Agreement represents a strategic investment in evidence-based policymaking, professional excellence and institutional development. It reinforces a regulatory model in which public health, patient safety and scientific quality remain the guiding principles of every regulatory decision.